Detalles de la búsqueda
1.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
Eur J Immunol
; 51(6): 1412-1422, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33576494
2.
Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study.
Antimicrob Agents Chemother
; 65(9): e0123721, 2021 08 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181475
3.
Quantitative and qualitative changes in anti-Neu5Gc antibody response following rabbit anti-thymocyte IgG induction in kidney allograft recipients.
Eur J Clin Invest
; 49(4): e13069, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30620396
4.
Polyclonal antibodies selectively inhibit tumor growth and invasion and synergize with immune checkpoint inhibitors.
JCI Insight
; 9(3)2024 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38085594
5.
Anti-SARS-CoV-2 glyco-humanized polyclonal antibody XAV-19: phase II/III randomized placebo-controlled trial shows acceleration to recovery for mild to moderate patients with COVID-19.
Front Immunol
; 15: 1330178, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38694503
6.
First-in-human Study With LIS1, a Next-generation Porcine Low Immunogenicity Antilymphocyte Immunoglobulin in Kidney Transplantation.
Transplantation
; 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421879
7.
LIS1, a glyco-humanized swine polyclonal anti-lymphocyte globulin, as a novel induction treatment in solid organ transplantation.
Front Immunol
; 14: 1137629, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36875084
8.
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.
Front Immunol
; 14: 1208705, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37187748
9.
Effect of Swine Glyco-humanized Polyclonal Neutralizing Antibody on Survival and Respiratory Failure in Patients Hospitalized With Severe COVID-19: A Randomized, Placebo-Controlled Trial.
Open Forum Infect Dis
; 10(11): ofad525, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942459
10.
XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants.
Front Immunol
; 12: 761250, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34868003
11.
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial.
Trials
; 22(1): 199, 2021 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33750432
12.
High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2.
bioRxiv
; 2020 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013271
13.
Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs.
PLoS One
; 11(6): e0156775, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27280712
Resultados
1 -
13
de 13
1
Próxima >
>>